Annual Net Income
$1.32 M
-$59.40 M-97.83%
31 December 2023
Summary:
Supernus Pharmaceuticals annual net profit is currently $1.32 million, with the most recent change of -$59.40 million (-97.83%) on 31 December 2023. During the last 3 years, it has fallen by -$125.63 million (-98.96%). SUPN annual net income is now -98.96% below its all-time high of $126.95 million, reached on 31 December 2020.SUPN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$38.50 M
+$18.58 M+93.30%
30 September 2024
Summary:
Supernus Pharmaceuticals quarterly net profit is currently $38.50 million, with the most recent change of +$18.58 million (+93.30%) on 30 September 2024. Over the past year, it has increased by +$54.47 million (+340.97%). SUPN quarterly net income is now -53.04% below its all-time high of $81.97 million, reached on 31 December 2011.SUPN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$59.71 M
+$54.47 M+1039.76%
30 September 2024
Summary:
Supernus Pharmaceuticals TTM net profit is currently $59.71 million, with the most recent change of +$54.47 million (+1039.76%) on 30 September 2024. Over the past year, it has increased by +$34.09 million (+133.05%). SUPN TTM net income is now -53.82% below its all-time high of $129.31 million, reached on 30 September 2020.SUPN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -97.8% | +341.0% | +133.1% |
| 3 y3 years | -99.0% | +78.5% | -27.0% |
| 5 y5 years | -98.8% | +33.4% | -43.6% |
SUPN Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.0% | at low | at high | +341.0% | -27.0% | +485.0% |
| 5 y | 5 years | -99.0% | at low | -3.8% | +341.0% | -53.8% | +485.0% |
| alltime | all time | -99.0% | +101.4% | -53.0% | +240.7% | -53.8% | +164.7% |
Supernus Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $38.50 M(+93.3%) | $59.71 M(+1039.8%) |
| June 2024 | - | $19.92 M(>+9900.0%) | $5.24 M(-133.8%) |
| Mar 2024 | - | $124.00 K(-89.4%) | -$15.51 M(-1278.4%) |
| Dec 2023 | $1.32 M(-97.8%) | $1.18 M(-107.4%) | $1.32 M(-94.9%) |
| Sept 2023 | - | -$15.98 M(+1822.5%) | $25.62 M(-40.9%) |
| June 2023 | - | -$831.00 K(-104.9%) | $43.35 M(-16.7%) |
| Mar 2023 | - | $16.95 M(-33.5%) | $52.04 M(-14.3%) |
| Dec 2022 | $60.71 M(+13.6%) | $25.48 M(+1356.9%) | $60.71 M(+61.2%) |
| Sept 2022 | - | $1.75 M(-77.8%) | $37.67 M(-34.5%) |
| June 2022 | - | $7.87 M(-69.3%) | $57.48 M(-21.6%) |
| Mar 2022 | - | $25.62 M(+949.0%) | $73.35 M(+37.3%) |
| Dec 2021 | $53.42 M(-57.9%) | $2.44 M(-88.7%) | $53.42 M(-34.6%) |
| Sept 2021 | - | $21.56 M(-9.1%) | $81.75 M(-18.4%) |
| June 2021 | - | $23.73 M(+316.7%) | $100.19 M(-9.8%) |
| Mar 2021 | - | $5.69 M(-81.5%) | $111.13 M(-12.5%) |
| Dec 2020 | $126.95 M(+12.3%) | $30.77 M(-23.1%) | $126.95 M(-1.8%) |
| Sept 2020 | - | $40.00 M(+15.4%) | $129.31 M(+9.4%) |
| June 2020 | - | $34.67 M(+61.1%) | $118.17 M(+1.7%) |
| Mar 2020 | - | $21.52 M(-35.0%) | $116.23 M(+2.8%) |
| Dec 2019 | $113.06 M(+1.9%) | $33.13 M(+14.8%) | $113.06 M(+6.8%) |
| Sept 2019 | - | $28.86 M(-11.8%) | $105.82 M(+0.8%) |
| June 2019 | - | $32.73 M(+78.4%) | $104.97 M(+1.9%) |
| Mar 2019 | - | $18.34 M(-29.2%) | $102.98 M(-7.2%) |
| Dec 2018 | $110.99 M(+93.8%) | $25.89 M(-7.6%) | $110.99 M(+12.4%) |
| Sept 2018 | - | $28.01 M(-8.9%) | $98.76 M(+13.9%) |
| June 2018 | - | $30.74 M(+16.6%) | $86.71 M(+18.2%) |
| Mar 2018 | - | $26.35 M(+92.9%) | $73.34 M(+28.0%) |
| Dec 2017 | $57.28 M | $13.66 M(-14.4%) | $57.28 M(-1.1%) |
| Sept 2017 | - | $15.96 M(-8.1%) | $57.95 M(-44.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $17.37 M(+68.7%) | $103.81 M(+7.4%) |
| Mar 2017 | - | $10.30 M(-28.1%) | $96.69 M(+6.0%) |
| Dec 2016 | $91.22 M(+554.2%) | $14.32 M(-76.8%) | $91.22 M(+8.9%) |
| Sept 2016 | - | $61.83 M(+503.1%) | $83.75 M(+224.1%) |
| June 2016 | - | $10.25 M(+112.5%) | $25.84 M(+43.3%) |
| Mar 2016 | - | $4.83 M(-29.6%) | $18.03 M(+29.3%) |
| Dec 2015 | $13.94 M(-227.6%) | $6.85 M(+75.0%) | $13.94 M(+28.2%) |
| Sept 2015 | - | $3.92 M(+60.7%) | $10.88 M(+136.9%) |
| June 2015 | - | $2.44 M(+230.2%) | $4.59 M(-14.3%) |
| Mar 2015 | - | $738.00 K(-80.5%) | $5.36 M(-149.0%) |
| Dec 2014 | -$10.93 M(-88.2%) | $3.79 M(-259.8%) | -$10.92 M(-70.6%) |
| Sept 2014 | - | -$2.37 M(-174.0%) | -$37.12 M(-36.9%) |
| June 2014 | - | $3.20 M(-120.6%) | -$58.84 M(-34.2%) |
| Mar 2014 | - | -$15.54 M(-30.6%) | -$89.40 M(-3.1%) |
| Dec 2013 | -$92.27 M(+99.4%) | -$22.41 M(-7.0%) | -$92.27 M(+10.7%) |
| Sept 2013 | - | -$24.10 M(-11.9%) | -$83.38 M(+14.6%) |
| June 2013 | - | -$27.36 M(+48.6%) | -$72.77 M(+31.3%) |
| Mar 2013 | - | -$18.41 M(+36.3%) | -$55.42 M(+19.7%) |
| Dec 2012 | -$46.28 M(-186.0%) | -$13.51 M(+0.2%) | -$46.28 M(-194.1%) |
| Sept 2012 | - | -$13.48 M(+34.6%) | $49.20 M(-7.1%) |
| June 2012 | - | -$10.01 M(+7.9%) | $52.95 M(-4.7%) |
| Mar 2012 | - | -$9.28 M(-111.3%) | $55.59 M(+3.3%) |
| Dec 2011 | $53.81 M(-239.9%) | $81.97 M(-942.2%) | $53.81 M(-246.5%) |
| Sept 2011 | - | -$9.73 M(+32.0%) | -$36.73 M(+36.1%) |
| June 2011 | - | -$7.38 M(-33.2%) | -$27.00 M(+37.6%) |
| Mar 2011 | - | -$11.05 M(+28.9%) | -$19.62 M(+128.9%) |
| Dec 2010 | -$38.46 M(-8461.5%) | -$8.57 M(+4.7%) | -$8.57 M(+4.7%) |
| Dec 2009 | $460.00 K(-101.4%) | -$8.19 M | -$8.19 M |
| Dec 2008 | -$33.48 M(+93.8%) | - | - |
| Dec 2007 | -$17.27 M | - | - |
FAQ
- What is Supernus Pharmaceuticals annual net profit?
- What is the all time high annual net income for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual net income year-on-year change?
- What is Supernus Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly net income year-on-year change?
- What is Supernus Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM net income year-on-year change?
What is Supernus Pharmaceuticals annual net profit?
The current annual net income of SUPN is $1.32 M
What is the all time high annual net income for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual net profit is $126.95 M
What is Supernus Pharmaceuticals annual net income year-on-year change?
Over the past year, SUPN annual net profit has changed by -$59.40 M (-97.83%)
What is Supernus Pharmaceuticals quarterly net profit?
The current quarterly net income of SUPN is $38.50 M
What is the all time high quarterly net income for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly net profit is $81.97 M
What is Supernus Pharmaceuticals quarterly net income year-on-year change?
Over the past year, SUPN quarterly net profit has changed by +$54.47 M (+340.97%)
What is Supernus Pharmaceuticals TTM net profit?
The current TTM net income of SUPN is $59.71 M
What is the all time high TTM net income for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM net profit is $129.31 M
What is Supernus Pharmaceuticals TTM net income year-on-year change?
Over the past year, SUPN TTM net profit has changed by +$34.09 M (+133.05%)